Oral AMXT 1501 Dicaprate in Combination With IV DFMO
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Head and Neck Cancer
Related studies linked through entity extraction aliases.
Real-time Margin Assessment in Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Carotid Ultrasound to Identify Head and Neck Cancer Survivors With High Cardiovascular Risk After Radiation Therapy
- Status
- COMPLETED
- Phase
- N/A
The Head and Neck Registry of the European Reference Network on Rare Adult Solid Cancers
- Status
- RECRUITING
- Phase
- N/A
Haemorrhage Risk Reduction Using Endovascular Embolisation in Place of Vessel Ligation for Patients Undergoing Transoral Robotic Surgery (HELPR)
- Status
- UNKNOWN
- Phase
- NA
Oral AHR Antagonist in Combination With Nivolumab in Patients With PD-1 Resistant Metastatic or Recurrent Head and Neck Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
Building a Renewed ImaGe After Head & Neck Cancer Treatment (BRIGHT) Multi-Site RCT
- Status
- RECRUITING
- Phase
- NA
Immunological Variables Associated to ICI Toxicity in Cancer Patients
- Status
- UNKNOWN
- Phase
- PHASE2
Imaging Study on Halcyon 4.0 System for Patients Receiving Radiation Therapy
- Status
- COMPLETED
- Phase
- NA
A Study of Pembrolizumab in Combination With Chemotherapy for Head and Neck Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Hospital Acquired Pneumonia in Temporary Tracheostomy
- Status
- UNKNOWN
- Phase
- N/A
Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O)
- Status
- RECRUITING
- Phase
- N/A
SOTO: Treatment Sensitivity of Organoids to Predict Treatment Outcome
- Status
- RECRUITING
- Phase
- N/A
Investigation of Effects of Physiotherapy Interventions on Mechanical Properties of Muscle in Head and Neck Cancer
- Status
- COMPLETED
- Phase
- NA
FT536 Monotherapy and in Combination With Monoclonal Antibodies in Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
InGReS: Intra-treatment Image Guided Adaptive Radiotherapy Dose-escalation Study
- Status
- UNKNOWN
- Phase
- NA
Trial Comparing Different Follow-up Strategies
- Status
- TERMINATED
- Phase
- NA
Phase III Xevinapant (Debio 1143) and Radiotherapy in Resected LA SCCHN, High Risk, Cisplatin-ineligible Participants (XRAY VISION)
- Status
- TERMINATED
- Phase
- PHASE3
Individualized Follow-Up for Head and Neck Cancer
- Status
- RECRUITING
- Phase
- N/A
Immune Biomarker Study for Head and Neck Cancer
- Status
- RECRUITING
- Phase
- N/A